Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Agilent Technologies Inc.

< Previous 1 2 3 4 5 6 Next >
Agilent Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces Collaboration with APC on Real-Time Process Monitoring
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces Cash Dividend of 21 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Joins AMBIC to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Participate at Cowen and Barclays Health Care Conferences
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Reports First-Quarter Fiscal Year 2022 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Highlights Integrated Automation Solutions at SLAS 2022
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent and A*STAR’s SIFBI Sign Research Collaboration Agreement to Advance Singapore Agri-Food Industry
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces the Innovative Seahorse XF Pro Analyzer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Webcast First-Quarter Fiscal Year 2022 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Presents Thought Leader Award to Professor Jason Kovacic
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Present at Evercore ISI Virtual Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
From Agilent Technologies Inc.
Via Business Wire
Tickers A
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
From Agilent Technologies Inc.
Via Business Wire
Tickers A
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.